Skip to main content
SpringerLink
Log in

Optimizing Nutrition to Delay Age Related Macular Degeneration

  • Chapter
Preventive Nutrition

Part of the book series: Nutrition and Health ((NH))

  • 2508 Accesses

Abstract

Age related macular degeneration (AMD) is the leading cause of visual loss in older adults, affecting 30–50 million individuals worldwide and over two million individuals in the USA (Ann Med 38(7):450–71, 2006; Facts about age-related macular degeneration, NIoH; 2010]. Over 15 % of the elderly are affected. While AMD does not result in complete blindness on its own, the loss of central vision can impair the ability to perform everyday activities, decreasing quality of life (Mol Aspects Med 33(4):318–75, 2012). Costs associated with AMD are in excess of $340 billion in the USA, and for the majority of AMD patients in the USA, there is no clinical treatment (Ann Med 38(7):450–71, 2006). Given the aging population, and changing diets toward diets that may enhance risk for AMD (see below), the prevalence of AMD is projected to grow, with over five million individuals being affected by 2050 (Facts about age-related macular degeneration, NIoH; 2010). Treatment options for AMD are limited to treating only the most advanced stages of AMD, and for only the 15 % of AMD sufferers with “wet” AMD, in which some vision is already lost (Nutrients 5(7):2405–56, 2013). Given the limited therapeutic options available for AMD, preventative interventions through dietary modification are attractive strategies. Here we review studies that suggest benefits of certain nutrients with respect to AMD, with few, if any, adverse side effects. For an exhaustive review of the literature available for these nutrients please see review by Weikel et al. (Mol Aspects Med. 33(4):318–75, 2012).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration—emerging pathogenetic and therapeutic concepts. Ann Med. 2006;38(7):450–71.

    Article  PubMed  Google Scholar 

  2. National Eye Institute. Facts about age-related macular degeneration. Bethesda: NIoH; 2010.

    Google Scholar 

  3. Weikel KA, Chiu CJ, Taylor A. Nutritional modulation of age-related macular degeneration. Mol Aspects Med. 2012;33(4):318–75.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Schleicher M, Weikel K, Garber C, Taylor A. Diminishing risk for age-related macular degeneration with nutrition: a current view. Nutrients. 2013;5(7):2405–56.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–72.

    Article  PubMed  Google Scholar 

  6. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology. 2012;119(3):571–80.

    Article  PubMed  Google Scholar 

  7. Gorin MB, Breitner JC, De Jong PT, Hageman GS, Klaver CC, Kuehn MH, et al. The genetics of age-related macular degeneration. Mol Vis. 1999;5:29.

    PubMed  CAS  Google Scholar 

  8. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419–21.

    Article  PubMed  CAS  Google Scholar 

  10. Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A, Postel EA, et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci. 2006;47:329–35.

    Article  PubMed  Google Scholar 

  11. Gorin MB. Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med. 2012;33(4):467–86.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Edwards AO. Genetic testing for age-related macular degeneration. Ophthalmology. 2006;113:509–10.

    Article  PubMed  Google Scholar 

  13. Edwards AO, Malek G. Molecular genetics of AMD and current animal models. Angiogenesis. 2007;10(2):119–32.

    Article  PubMed  CAS  Google Scholar 

  14. Edwards AO, Ritter 3rd R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308(5720):421–4.

    Article  PubMed  CAS  Google Scholar 

  15. Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Javier Nieto F, Huang GH, et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol. 2010;128(6):750–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Peeters A, Magliano DJ, Stevens J, Duncan BB, Klein R, Wong TY. Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch Ophthalmol. 2008;126(11):1554–60.

    Article  PubMed  Google Scholar 

  17. Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981;34(3):362–6.

    PubMed  CAS  Google Scholar 

  18. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76(1):5–56.

    PubMed  CAS  Google Scholar 

  19. Chiu CJ, Taylor A. Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res. 2011;30(1):18–53.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Chiu C-J, Liu S, Willett WC, Wolever TMS, Brand-Miller JC, Barclay AC, Taylor A. Informing food choices and health outcomes by use of the dietary glycemic index. Nutr Rev. 2011;69(4):231–42.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chiu CJ, Milton RC, Gensler G, Taylor A. Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. Am J Clin Nutr. 2007;86(1):180–8.

    PubMed  CAS  Google Scholar 

  22. Uchiki T, Weikel KA, Jiao W, Shang F, Caceres A, Pawlak DB, et al. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in non diabetics). Aging Cell. 2012;11(1):1–13.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Chiu CJ, Klein R, Milton RC, Gensler G, Taylor A. Does eating particular diets alter risk of age-related macular degeneration in users of the age-related eye disease study supplements? Br J Ophthalmol. 2009;1241–6.

    Google Scholar 

  24. Brand-Miller J. Glycemic index and body weight. Am J Clin Nutr. 2005;81(3):722–3. author reply 3-4.

    PubMed  CAS  Google Scholar 

  25. Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA. 2002;287:2414–23.

    Article  PubMed  CAS  Google Scholar 

  26. AHA. Know Your Fats: American Heart Association; 2014 [cited 2014 July 21]. Available from: http://www.heart.org/HEARTORG/Conditions/Cholesterol/PreventionTreatmentofHighCholesterol/Know-Your-Fats_UCM_305628_Article.jsp.

  27. Schweigert FJ, Reimann J. Micronutrients and their relevance for the eye—function of lutein, zeaxanthin and omega-3 fatty acids. Klin Monbl Augenheilkd. 2011;228(6):537–43.

    Article  PubMed  CAS  Google Scholar 

  28. Pilkington SM, Watson RE, Nicolaou A, Rhodes LE. Omega-3 polyunsaturated fatty acids: photoprotective macronutrients. Exp Dermatol. 2011;20(7):537–43.

    Article  PubMed  CAS  Google Scholar 

  29. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris 3rd FL, Gensler GR, et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol. 2007;125(5):671–9.

    Article  PubMed  CAS  Google Scholar 

  30. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US twin study of age-related macular degeneration. Arch Ophthalmol. 2006;124(7):995–1001.

    Article  PubMed  CAS  Google Scholar 

  31. Christen WG, Schaumberg DA, Glynn RJ, Buring JE. Dietary omega-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch Ophthalmol. 2011;129(7):921–9.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M. Dietary fat and age-related maculopathy [see comments]. Arch Ophthalmol. 1995;113(6):743–8.

    Article  PubMed  CAS  Google Scholar 

  33. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol. 2001;119(8):1191–9.

    Article  PubMed  CAS  Google Scholar 

  34. Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol. 2000;118(3):401–4.

    Article  PubMed  CAS  Google Scholar 

  35. Swenor BKBS, Caulfield L, West SK. The impact of fish and shellfish consumption on age-related macular degeneration. Ophthalmology. 2010;117(12):2395–401.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Parekh N, Voland RP, Moeller SM, Blodi BA, Ritenbaugh C, Chappell RJ, et al. Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women’s Health Initiative. Arch Ophthalmol. 2009;127(11):1483–93.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Bonds DE, Harrington M, Worrall BB, Bertoni AG, Eaton CB, Hsia J, et al. Effect of long-chain omega-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA Intern Med. 2014;174(5):763–71.

    Article  PubMed  CAS  Google Scholar 

  38. Robman L, Vu H, Hodge A, Tikellis G, Dimitrov P, McCarty C, et al. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol. 2007;42(5):720–6.

    Article  PubMed  Google Scholar 

  39. Chong EW, Robman LD, Simpson JA, Hodge AM, Aung KZ, Dolphin TK, et al. Fat consumption and its association with age-related macular degeneration. Arch Ophthalmol. 2009;127(5):674–80.

    Article  PubMed  CAS  Google Scholar 

  40. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268–73.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Delcourt C, Carriere I, Cristol JP, Lacroux A, Gerber M. Dietary fat and the risk of age-related maculopathy: the POLANUT study. Eur J Clin Nutr. 2007;61(11):1341–4.

    Article  PubMed  CAS  Google Scholar 

  42. Sacks FM, Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med. 2002;113(Suppl 9B):13S–24.

    Article  PubMed  CAS  Google Scholar 

  43. Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon JM, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001;73(2):209–18.

    PubMed  CAS  Google Scholar 

  44. Granado F, Olmedilla B, Blanco I. Nutritional and clinical relevance of lutein in human health. Br J Nutr. 2003;90(3):487–502.

    Article  PubMed  CAS  Google Scholar 

  45. Dietzel M, Zeimer M, Heimes B, Claes B, Pauleikhoff D, Hense HW. Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS). Invest Ophthalmol Vis Sci. 2011;52(6):3452–7.

    Article  PubMed  Google Scholar 

  46. Schalch W, Cohn W, Barker FM, Kopcke W, Mellerio J, Bird AC, et al. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin—the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys. 2007;458(2):128–35.

    Article  PubMed  CAS  Google Scholar 

  47. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001;385:28–40.

    Article  PubMed  CAS  Google Scholar 

  48. Hammond Jr BR, Johnson EJ, Russell RM, Krinsky NI, Yeum K-J, Edwards RB, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997;38:1795–801.

    PubMed  Google Scholar 

  49. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994;272(7279):1413–20.

    Article  PubMed  CAS  Google Scholar 

  50. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 1993;111(6358):104–9.

    Google Scholar 

  51. Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CB. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand. 2002;80(4):368–71.

    Article  PubMed  CAS  Google Scholar 

  52. Mares-Perlman JA, Fisher AI, Klein R, Palta M, Block G, Millen AE, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. 2001;153:424–32.

    Article  PubMed  CAS  Google Scholar 

  53. Krishnadev N, Meleth AD, Chew EY. Nutritional supplements for age-related macular degeneration. Curr Opin Ophthalmol. 2010;21(3):184–9.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75(4):216–30.

    Article  PubMed  Google Scholar 

  55. Fletcher AE, Bentham GC, Agnew M, Young IS, Augood C, Chakravarthy U, et al. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol. 2008;126(10):1396–403.

    Article  PubMed  Google Scholar 

  56. Michikawa T, Ishida S, Nishiwaki Y, Kikuchi Y, Tsuboi T, Hosoda K, et al. Serum antioxidants and age-related macular degeneration among older Japanese. Asia Pac J Clin Nutr. 2009;18(1):1–7.

    PubMed  CAS  Google Scholar 

  57. Cardinault N, Abalain JH, Sairafi B, Coudray C, Grolier P, Rambeau M, et al. Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients. Clin Chim Acta. 2005;357:34–42.

    Article  PubMed  CAS  Google Scholar 

  58. Sanders TAB, Haines AP, Wormald R, Wright LA, Obeid O. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr. 1993;57(7114):428–33.

    PubMed  CAS  Google Scholar 

  59. Seddon JM, Reynolds R, Rosner B. Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis. 2010;16:2412–24.

    PubMed  PubMed Central  CAS  Google Scholar 

  60. Mares-Perlman JA, Brady WE, Klein R, Klein BE, Bowen P, Stacewicz-Sapuntzakis M, et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol. 1995;113(12):1518–23.

    Article  PubMed  CAS  Google Scholar 

  61. Mares-Perlman J, Klein R, Klein BEK, Greger JL, Brady WE, Palta M, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 1996;114:991–7.

    Article  PubMed  CAS  Google Scholar 

  62. Richer SP, Stiles W, Graham-Hoffman K, Levin M, Ruskin D, Wrobel J, et al. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry. 2011;82(11):667–80.

    Article  PubMed  Google Scholar 

  63. Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris 3rd FL, Elman MJ, et al. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol. 2014;132(2):142–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Aronow ME, Chew EY. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions. Curr Opin Ophthalmol. 2014;25(3):186–90.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2008;115(2):334–41.

    Article  PubMed  Google Scholar 

  66. Evans JR, Henshaw K. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev. 2008;23(1).

    Google Scholar 

  67. Zampatti S, Ricci F, Cusumano A, Marsella LT, Novelli G, Giardina E. Review of nutrient actions on age-related macular degeneration. Nutr Res. 2014;34(2):95–105.

    Article  PubMed  CAS  Google Scholar 

  68. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst. 1996;88(21):1560–70.

    Article  PubMed  CAS  Google Scholar 

  69. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol. 1998;148(2):204–14.

    Article  PubMed  CAS  Google Scholar 

  70. Maiani G, Caston MJ, Catasta G, Toti E, Cambrodon IG, Bysted A, et al. Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol Nutr Food Res. 2009;53 Suppl 2:S194–218.

    Article  PubMed  Google Scholar 

  71. Simonelli F, Zarrilli F, Mazzeo S, Verde V, Romano N, Savoia M, et al. Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy. Clin Chim Acta. 2002;320:111–5.

    Article  PubMed  CAS  Google Scholar 

  72. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MOM. Factors associated with age-related macular degeneration. Am J Epidemiol. 1988;128(4633):700–10.

    PubMed  CAS  Google Scholar 

  73. Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol. 2007;125(5):661–9.

    Article  PubMed  CAS  Google Scholar 

  74. Millen AE, Voland R, Sondel SA, Parekh N, Horst RL, Wallace RB, et al. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol. 2011;129(4):481–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Belda JI, Roma J, Vilela C, Puertas FJ, Diaz-Llopis M, Bosch-Morell F, et al. Serum vitamin E levels negatively correlate with severity of age-related macular degeneration. Mech Ageing Dev. 1999;107(2):159–64.

    Article  PubMed  CAS  Google Scholar 

  76. Ishihara N, Yuzawa M, Tamakoshi A. Antioxidants and angiogenetic factor associated with age-related macular degeneration (exudative type). Nippon Ganka Gakkai Zasshi. 1997;101:248–51.

    PubMed  CAS  Google Scholar 

  77. Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l’Age. Arch Ophthalmol. 1999;117(10):1384–90.

    Article  PubMed  CAS  Google Scholar 

  78. Chiu CJ, Milton RC, Klein R, Gensler G, Taylor A. Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. Ophthalmology. 2009;116(5):939–46.

    Article  PubMed  PubMed Central  Google Scholar 

  79. West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol. 1994;112:222–7.

    Article  PubMed  CAS  Google Scholar 

  80. van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA. 2005;294(24):3101–7.

    Article  PubMed  Google Scholar 

  81. Morris MS, Jacques PF, Chylack LT, Hankinson SE, Willett WC, Hubbard LD, et al. Intake of zinc and antioxidant micronutrients and early age-related maculopathy lesions. Ophthalmic Epidemiol. 2007;14(5):288–98.

    Article  PubMed  Google Scholar 

  82. Klein BE, Knudtson MD, Lee KE, Reinke JO, Danforth LG, Wealti AM, et al. Supplements and age-related eye conditions the beaver dam eye study. Ophthalmology. 2008;115(7):1203–8.

    Article  PubMed  Google Scholar 

  83. Weikel K, Shang F, Taylor A. Consumption of high glycemic index diet up-regulates markers of metabolic and cellular stress. 2011 (in press).

    Google Scholar 

  84. King JC. Zinc: an essential but elusive nutrient. Am J Clin Nutr. 2011;94(2):679S–84.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Kuzniarz M, Mitchell P, Flood VM, Wang JJ. Use of vitamin and zinc supplements and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2002;9(4):283–95.

    Article  PubMed  Google Scholar 

  86. Group A-REDSR. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119(10):1439–52.

    Article  Google Scholar 

  87. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106:192–8.

    Article  PubMed  CAS  Google Scholar 

  88. Newsome DA. A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration. Curr Eye Res. 2008;33(7):591–8.

    Article  PubMed  CAS  Google Scholar 

  89. Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1225–35.

    PubMed  CAS  Google Scholar 

  90. NEI. What the Age-Related Eye Disease Studies Mean for You: National Eye Institute; 2013 [cited 2014 July 21]. Available from: http://www.nei.nih.gov/areds2/PatientFAQ.asp.

  91. Chew EY, Lindblad AS, Clemons T. Summary results and recommendations from the age-related eye disease study. Arch Ophthalmol. 2009;127(12):1678–9.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Group A-REDSR. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–36.

    Article  Google Scholar 

  93. Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S. Carotenoids and antioxidants in age-related maculopathy Italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology. 2008;115(2):324–33. e2.

    Article  PubMed  Google Scholar 

  94. Richer S. Multicenter ophthalmic and nutritional age-related macular degeneration study—part 2: antioxidant intervention and conclusions. J Am Optom Assoc. 1996;67(1):30–49.

    PubMed  CAS  Google Scholar 

  95. Cangemi FE. TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD. BMC Ophthalmol. 2007;7:3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Christen WG. Antioxidant vitamins and age-related eye disease. Proc Assoc Am Physicians. 1999;111(1):16–21.

    Article  PubMed  CAS  Google Scholar 

  97. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004;122:883–92.

    Article  PubMed  Google Scholar 

  98. Chiu CJ, Chang ML, Zhang FF, Li T, Gensler G, Schleicher M, et al. The relationship of major American dietary patterns to age-related macular degeneration. Am J Ophthalmol. 2014;158(1):118–27.e1.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Amirul Islam FM, Chong EW, Hodge AM, Guymer RH, Aung KZ, Makeyeva GA, et al. Dietary patterns and their associations with age-related macular degeneration: the Melbourne collaborative cohort study. Ophthalmology. 2014;121(7):1428–34.e2.

    Article  PubMed  Google Scholar 

  100. Mares JA, Voland RP, Sondel SA, Millen AE, Larowe T, Moeller SM, et al. Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol. 2011;129(4):470–80.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Disclaimer

Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the US Department of Agriculture.

Author information

Authors and Affiliations

  1. Rowan University SOM, Stratford, NJ, USA

    Molly Schleicher

  2. White Technical Research, Argenta, IL, USA

    Elizabeth Whitcomb

  3. Laboratory for Nutrition and Vision Research, USDA Human Nutrition Research Center on Aging, Tufts University, 711 Washington St., Boston, MA, 02111, USA

    Allen Taylor

Authors
  1. Molly Schleicher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Whitcomb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allen Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Allen Taylor .

Editor information

Editors and Affiliations

  1. Consultants in Consumer Healthcare, Morristown, New Jersey, USA

    Adrianne Bendich

  2. Columbia University Inst. Human Nutrition, New York, New York, USA

    Richard J. Deckelbaum

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Schleicher, M., Whitcomb, E., Taylor, A. (2015). Optimizing Nutrition to Delay Age Related Macular Degeneration. In: Bendich, A., Deckelbaum, R. (eds) Preventive Nutrition. Nutrition and Health. Springer, Cham. https://doi.org/10.1007/978-3-319-22431-2_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22431-2_27

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22430-5

  • Online ISBN: 978-3-319-22431-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation